BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18239068)

  • 21. Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK.
    Zhu Y; Zhang T; Xie S; Tu R; Cao Y; Guo X; Zhou J; Zhou X; Cao L
    Biomed Pharmacother; 2012 Dec; 66(8):569-77. PubMed ID: 23102719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the proliferative capacity of the flavanones 8-prenylnaringenin, 6-(1.1-dimethylallyl)naringenin and naringenin in MCF-7 cells and the rat mammary gland.
    Helle J; Kräker K; Bader MI; Keiler AM; Zierau O; Vollmer G; Welsh J; Kretzschmar G
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):125-35. PubMed ID: 24859648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the chemically synthesized flavanone 7-(O-prenyl)naringenin-4'-acetate on the estrogen signaling pathway in vivo and in vitro.
    Kretzschmar G; Vollmer G; Schwab P; Tischer S; Metz P; Zierau O
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):114-9. PubMed ID: 17631998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogenic and antiestrogenic activities of 2,4-diphenylfuran-based ligands of estrogen receptors alpha and beta.
    Zimmermann J; von Angerer E
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):259-68. PubMed ID: 17475477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells.
    Wu F; Safe S
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):1-9. PubMed ID: 17141713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of estrogen receptors, PKC and Src in ERK2 and p38 MAPK signaling triggered by 17β-estradiol in skeletal muscle cells.
    Ronda AC; Buitrago C; Boland R
    J Steroid Biochem Mol Biol; 2010 Oct; 122(4):287-94. PubMed ID: 20478382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer.
    Song RX; Fan P; Yue W; Chen Y; Santen RJ
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S3-13. PubMed ID: 17259556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 8-Prenylnaringenin, inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells.
    Brunelli E; Minassi A; Appendino G; Moro L
    J Steroid Biochem Mol Biol; 2007; 107(3-5):140-8. PubMed ID: 17681752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of estrogen receptor (ER) alpha in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells.
    Zhang S; Li X; Burghardt R; Smith R; Safe SH
    J Mol Endocrinol; 2005 Dec; 35(3):433-47. PubMed ID: 16326831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
    Collins-Burow BM; Burow ME; Duong BN; McLachlan JA
    Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype.
    Pallottini V; Segatto M; Acconcia F; Fiocchetti M; Marino M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the MAPK pathway alone is insufficient to account for all of the cytotoxic effects of naringenin in MCF-7 breast cancer cells.
    Eanes L; Patel YM
    Biochim Open; 2016 Dec; 3():64-71. PubMed ID: 29450133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of membrane ERα signaling in bone and other major estrogen responsive tissues.
    Gustafsson KL; Farman H; Henning P; Lionikaite V; Movérare-Skrtic S; Wu J; Ryberg H; Koskela A; Gustafsson JÅ; Tuukkanen J; Levin ER; Ohlsson C; Lagerquist MK
    Sci Rep; 2016 Jul; 6():29473. PubMed ID: 27388455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.
    Collins-Burow BM; Antoon JW; Frigo DE; Elliott S; Weldon CB; Boue SM; Beckman BS; Curiel TJ; Alam J; McLachlan JA; Burow ME
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):186-93. PubMed ID: 22634477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.